SCHEMBL15712876

SCHEMBL15712876

O=C(O)c1cc(Cl)ccc1Nc1ccc2c(c1)[nH]c(=O)n2Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.54
LMNA P02545 4/20 0.49
HTT P42858 1/20 0.49
MPO P05164 1/20 0.46
DHODH Q02127 1/20 0.45
EPHX2 P34913 3/20 0.45
CA9 Q16790 1/20 0.45
MDM2 Q00987 3/20 0.44
PPARG P37231 2/20 0.44
POLB P06746 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
KDM4E B2RXH2 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
THRB P10828 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15712555 0.90 PGR (0.50) PGRLMNAHTTEPHX2MDM2
SCHEMBL15712614 0.81 MPO (0.46) LMNAMPODHODHCA9POLB
SCHEMBL5243425 0.81 LMNA (0.64) PGRLMNAHTTEPHX2MDM2
SCHEMBL15712717 0.80 KDM4E (0.48) LMNAMPODHODHCA9POLB
SCHEMBL15712546 0.80 MAPT (0.53) MPODHODHCA9POLBKMT2A
SCHEMBL15712705 0.80 HPD (0.46) LMNAMPODHODHCA9POLB
SCHEMBL5241978 0.79 PGR (0.57) PGRLMNAHTTEPHX2PPARG
SCHEMBL5242664 0.79 PGR (0.65) PGRLMNAHTTEPHX2MDM2
SCHEMBL15712349 0.79 DHODH (0.50) LMNAMPODHODHCA9POLB
SCHEMBL15712322 0.78 MPO (0.45) LMNAMPODHODHCA9PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2915804-B1 NOVEL AMINE DERIVATIVE OR SALT THEREOF AS TNF ALPHA INHIBITORS FUJIFILM TOYAMA CHEMICAL CO LTD (JP) 2019-03-27 EP disclosed
EP-2915804-B1 NOVEL AMINE DERIVATIVE OR SALT THEREOF AS TNF ALPHA INHIBITORS FUJIFILM TOYAMA CHEMICAL CO LTD (JP) 2019-03-27 EP disclosed
US-9624215-B2 Amine derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2017-04-18 US disclosed
US-9624215-B2 Amine derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2017-04-18 US disclosed
US-20150299189-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2015-10-22 US disclosed
US-20150299189-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2015-10-22 US disclosed
EP-2915804-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2015-09-09 EP disclosed
WO-2014069510-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF 富山化学工業株式会社 (JP) 2014-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299189-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF HRH4, CLIC4, KRT18 PGR 3129/4885LMNA 3053/4885HTT 4782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.